Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Puma Biotechnology Presents Updates from the SUMMIT Trial at the 2021 SABCS Annual Meeting: https://mms.businesswire.com/media/20191106005906/en/305625/5/puma_logo_JPEG.jpg
Puma Biotechnology Presents Updates from the SUMMIT Trial at the 2021 SABCS Annual Meeting


Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, presented an update from its Phase II SUMMIT trial at the ongoing 2021 San Antonio Breast Cancer Symposium (SABCS) Annual

DGAP-Adhoc: United Internet AG: Ralph Dommermuth assesses offers for block acquisitions of shares in United Internet AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png
DGAP-Adhoc: United Internet AG: Ralph Dommermuth assesses offers for block acquisitions of shares in United Internet AG
DGAP-Adhoc: United Internet AG: Ralph Dommermuth assesses offers for block acquisitions of shares in United Internet AG
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease


Vifor Pharma today announced that the first patient has been enrolled in a double-blind, randomized phase-IIa clinical trial evaluating the safety, efficacy and tolerability of vamifeport in adult

Pfizer Declares First-Quarter 2022 Dividendhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Declares First-Quarter 2022 Dividend


Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company’s common stock to $0.40 for the first-quarter 2022 dividend

DGAP-News: BP p.l.c.: Transaction in Own Shares: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23826/BP_logo.svg.png
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
Energy Secretary Jennifer M. Granholm Highlights Clean Energy Investments on Tour of Exelon Nuclear Plant: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24420/375px-Exelon_Corp_logo.png
Energy Secretary Jennifer M. Granholm Highlights Clean Energy Investments on Tour of Exelon Nuclear Plant


Exelon Corp. (Nasdaq: EXC) hosted U.S. Secretary of Energy Jennifer M. Granholm on a tour of Exelon’s Braidwood Generating Station in Will County to highlight the economic and environmental

Okta Joins the OpenID Foundation Board to Further Advance Open Identity Standards
Okta Joins the OpenID Foundation Board to Further Advance Open Identity Standards


Okta, Inc. (NASDAQ:OKTA), the leading independent provider of identity, today announced it has joined the OpenID Foundation as a sustaining member. The new board position for Okta follows

Cloudflare Joins Microsoft 365 Networking Partner Program; Optimizes Cloudflare’s Zero Trust Network for Microsoft Customers: https://mms.businesswire.com/media/20200719005029/en/738100/5/cf-logo-h-rgb.jpg
Cloudflare Joins Microsoft 365 Networking Partner Program; Optimizes Cloudflare’s Zero Trust Network for Microsoft Customers


Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, today announced it has joined the Microsoft 365 Networking Partner Program

European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis


Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved the 100 mg and 200 mg doses of Cibinqo® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor

RPM to Announce Fiscal 2022 Second-Quarter Results on January 5, 2022: https://mms.businesswire.com/media/20200903005685/en/818366/5/Rust-Oleum-logo+%28002%29.jpg
RPM to Announce Fiscal 2022 Second-Quarter Results on January 5, 2022


RPM International Inc. (NYSE: RPM) announced today that it will release its financial results for the fiscal 2022 second quarter ended November 30, 2021, before the stock market opens on Wednesday

Guidewire Announces NXT Level Technologies as New Consulting Alliance Partner: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Guidewire Announces NXT Level Technologies as New Consulting Alliance Partner


Guidewire (NYSE: GWRE) announced that NXT Level Technologies, an insurance IT services provider specializing in Guidewire products, has joined Guidewire PartnerConnect as a Consulting alliance

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Basware Climate Change Impact Score from CDP Again Beats IT/Software Development Sector Average
Basware Climate Change Impact Score from CDP Again Beats IT/Software Development Sector Average


Basware (Nasdaq: BAS1V) is pleased to announce that it received a “B” score, higher than its 2020 score, from CDP, a global non-profit that runs the world’s leading environmental disclosure

Victory Capital Reports November 2021 Assets Under Management: https://mms.businesswire.com/media/20200331005113/en/460034/5/VC_Logo_2c.jpg
Victory Capital Reports November 2021 Assets Under Management


Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today reported assets under management (AUM) of $160.5 billion as of November 30, 2021.

 


Victory Capital

CI Global Asset Management Announces ETF Mergers: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Global Asset Management Announces ETF Mergers


CI Global Asset Management (“CI GAM”) today announced a proposal to merge six exchange-traded funds into other ETFs as part of its continuing strategy to modernize its product lineup.



The

Philip Morris International Appoints Business Accelerator Dessi Temperley to its Board of Directors: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23874/225px-Philip_Morris_International_Logo.svg.png
Philip Morris International Appoints Business Accelerator Dessi Temperley to its Board of Directors


Philip Morris International Inc. (PMI) (NYSE: PM) today announced that on December 6, 2021, its Board of Directors appointed a new member, Ms. Dessislava (“Dessi”) Temperley.



Dessi Temperley is a

Philip Morris International Releases 10-Year Anniversary Report on Agricultural Labor Practices: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23874/225px-Philip_Morris_International_Logo.svg.png
Philip Morris International Releases 10-Year Anniversary Report on Agricultural Labor Practices


Today, in recognition of International Day of Human Rights and the International Year for the Elimination of Child Labor (2021), Philip Morris International Inc. (PMI) (NYSE: PM) publishes its

DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 46 / 2021) with DEGES
DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 46 / 2021) with DEGES
DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 46 / 2021) with DEGES
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23699/Aurubis-Logo.svg.png
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system
 Germany Slowly Joins Europe in Adopting Data Analytics: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
 Germany Slowly Joins Europe in Adopting Data Analytics


Germany lags behind most of Europe in digital transformation and the use of advanced analytics services but is gradually gaining momentum, according to two new research reports published today by

DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 45 / 2021) with ACCIONA
DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 45 / 2021) with ACCIONA
DGAP-News: RIB Software SE (RIB) signs a Phase-II-contract (No. 45 / 2021) with ACCIONA
Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg
Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.


Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and a leader in clinical diagnostics testing, announces a share purchase agreement with Transgenic Inc

Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee


Regulatory News:



AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR



Vifor Pharma Group today announced the appointment of Hervé Gisserot as Chief Commercial Officer and member of the Vifor Pharma

Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209006035/en/



AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR



Vifor

EQS-News: Swiss Re agrees to sell elipsLife to Swiss Life International and to enter into a long-term partnership supported by reinsurance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23982/Swiss_Re_2013_logo.svg.png
EQS-News: Swiss Re agrees to sell elipsLife to Swiss Life International and to enter into a long-term partnership supported by reinsurance
EQS-News: Swiss Re agrees to sell elipsLife to Swiss Life International and to enter into a long-term partnership supported by reinsurance